Genmab: Pushing for growth
Ex-Novartis Senior VP Judith Klimovsky has joined Copenhagen-based Genmab as Executive Vice President and Chief Development Officer. The appointment is meant to pave the way for the antibody specialist to grow into a global biotech company.
Klimovsky will be responsible for Genmabs product development strategy in line with the company’s corporate strategy. Most recently, she served as Senior Vice President and Global Head, Oncology Clinical Development, at Novartis. Klimovsky is a haematologist by training with extensive experience in various roles at BMS, Merck and Novartis.
Klimovsky will be based at the company’s Princeton, United States location, whilst travelling regularly to the company’s locations in Copenhagen, Denmark and Utrecht, The Netherlands.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium